Skip to content

Comparative study of 2 different combinations of drugs for pain relief by caudal block in paediatric patients undergoing surgeries below umbilicus

A Comparative study of Dexmedetomidine and Clonidine as adjuvants to Levobupivacaine for caudal analgesia in paediatric patients undergoing infraumbilical surgery: An observational study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/08/020924
Enrollment
64
Registered
2019-08-27
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Control Intervention1: GROUP- LC: Group LC- patients will recieve caudal 0.2% levobupivacaine 1ml/kg plus 2 µg/ kg clonidine Control Intervention2: GROUP- LD: Group LD- patients will recieve caudal 0

Sponsors

Dr SN Medical College Jodhpur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients undergoing infra umbilical surgeries aged between 2-10 years and belonging to ASA grade 1 & 2 who are willing to give informed risk consent will be taken up for study

Exclusion criteria

Exclusion criteria: 1. Patients/ relatives refusal 2. Children with coagulation disorders 3. Children with pre-existing neurological disease 4. Children with anatomic abnormalities of the spine 5. Infection at the local site 6. Children with known allergy to local anaesthetics

Design outcomes

Primary

MeasureTime frame
To compare the duration of post operative analgesia(T5,T9,T12, T14-T17), motor block(T3,T5-T11), vital parameters ( preop, intraop and postop) (T0-T5, T7-T11,T13,T14) in terms of Heart rate, Blood pressure, SPO2 and respiratory rate, and Sedation score( T3, T5-T11) at different time points.Timepoint: T0- preop T1- 5 min T2- 15min T3- 30 min T4- 45min T5- 60 min/ 1 hour/ post operative T6- 90 min T7- 120 min /2hour T8- 3hour T9- 4 hour T10- 5 hour T11- 6 hour T12- 8 hour T13- 9 hour T14- 12 hour T15- 16 hour T16- 20 hour T17-24 hour

Secondary

MeasureTime frame
Any side effect of the drugTimepoint: Side effects will be monitored upto 24 hours

Countries

India

Contacts

Public ContactDr Sarita Janweja

Dr S.N. Medical college Jodhpur

sarita.janweja@gmail.com9829116420

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026